{
    "nctId": "NCT04697043",
    "briefTitle": "The Benefit of Surgery in Stage IV of Breast Cancer",
    "officialTitle": "The Survival Benefit of Local Surgery in Stage IV of Breast Cancer",
    "overallStatus": "UNKNOWN",
    "conditions": "Breast Cancer Stage IV",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 212,
    "primaryOutcomeMeasure": "The number of participants with no more tumor in their body",
    "eligibilityCriteria": "Inclusion Criteria:\n\nPrimary confirmed distant metastatic breast cancer (M1); A histologically proven diagnosis of the breast tumor; A known hormonal and HER2Neu status; Having TNM classification: T1-T3, resectable T4 status, and N0-N3; - performance status and comorbidity should allow surgery and/or systemic therapy; Accepting the surgery by written informed consent.\n\nExclusion criteria are:\n\nNo confirmed primary invasive breast cancer in the medical history Having another malignancy within the last 10 years, besides basal cell carcinoma of the skin or early-stage cervical cancer Having the history of surgical treatment and/or radiotherapy of the breast tumor before randomization Having irresectable T4 breast tumor Having synchronous bilateral breast cancer.\n\n-",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}